These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15338754)

  • 1. Recent areas of development for dendritic cell vaccines.
    Morse MA; Chui S; Clay TM; Lyerly HK
    Cancer Chemother Biol Response Modif; 2003; 21():339-50. PubMed ID: 15338754
    [No Abstract]   [Full Text] [Related]  

  • 2. Dendritic cell-based vaccines and therapies for cancer.
    Tatsumi T; Storkus WJ
    Expert Opin Biol Ther; 2002 Dec; 2(8):919-28. PubMed ID: 12517270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells: a journey from laboratory to clinic.
    Cerundolo V; Hermans IF; Salio M
    Nat Immunol; 2004 Jan; 5(1):7-10. PubMed ID: 14699398
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetically modified dendritic cell-based cancer vaccines.
    Bubeník J
    Folia Biol (Praha); 2001; 47(5):153-5. PubMed ID: 11686430
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor vaccine strategies that employ dendritic cells and tumor lysates: experimental and clinical studies.
    Mulé JJ
    Immunol Invest; 2000 May; 29(2):127-9. PubMed ID: 10854180
    [No Abstract]   [Full Text] [Related]  

  • 6. Present and future of cancer vaccines.
    Hockertz S
    Toxicology; 2005 Oct; 214(1-2):151-61. PubMed ID: 16259078
    [No Abstract]   [Full Text] [Related]  

  • 7. Determinant spreading and tumor responses after peptide-based cancer immunotherapy.
    Ribas A; Timmerman JM; Butterfield LH; Economou JS
    Trends Immunol; 2003 Feb; 24(2):58-61. PubMed ID: 12547500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and future applications of cellular therapies for cancer.
    Copier J; Bodman-Smith M; Dalgleish A
    Immunotherapy; 2011 Apr; 3(4):507-16. PubMed ID: 21463192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer vaccines: dream, reality, or nightmare?
    Biagi E; Rousseau RF; Yvon E; Vigouroux S; Dotti G; Brenner MK
    Clin Exp Med; 2002 Nov; 2(3):109-18. PubMed ID: 12463196
    [No Abstract]   [Full Text] [Related]  

  • 10. T-cell epitope peptide vaccines.
    Elsawa SF; Rodeberg DA; Celis E
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DC-based cancer vaccines: lessons from clinical trials.
    Brody JD; Engleman EG
    Cytotherapy; 2004; 6(2):122-7. PubMed ID: 15203988
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer vaccines: finding the best way to train the immune system.
    Goldman B
    J Natl Cancer Inst; 2002 Oct; 94(20):1523-6. PubMed ID: 12381703
    [No Abstract]   [Full Text] [Related]  

  • 13. Current developments of immunotherapy in the clinic.
    Antonia S; Mulé JJ; Weber JS
    Curr Opin Immunol; 2004 Apr; 16(2):130-6. PubMed ID: 15023403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immunotherapy for cancer: current concepts and clinical perspectives scientific basis and approaches for therapeutic cancer vaccines. Part I.
    Quatan N; Spicer J; Plunkett T; Pandha H
    Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):356-65. PubMed ID: 15341440
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dendrite cell-based cancer vaccines--clinical application].
    Svane IM; Berntsen A; Trepiakas R; Pedersen AE
    Ugeskr Laeger; 2006 Apr; 168(14):1415-20. PubMed ID: 16584668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dendritic cell-based cancer immunotherapy].
    Aruga A
    Nihon Rinsho; 2010 Jun; 68(6):1107-10. PubMed ID: 20535963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer vaccines based on dendritic cells loaded with tumor-associated antigens.
    Burdin N; Moingeon P
    Cell Biol Toxicol; 2001; 17(2):67-75. PubMed ID: 11499697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of dendritic cell-based vaccines for cancer therapy.
    Reinhard G; Märten A; Kiske SM; Feil F; Bieber T; Schmidt-Wolf IG
    Br J Cancer; 2002 May; 86(10):1529-33. PubMed ID: 12085199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoengineering: how nanotechnology can enhance cancer immunotherapy.
    Goldberg MS
    Cell; 2015 Apr; 161(2):201-4. PubMed ID: 25860604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy: development of immunostimulatory treatments for cancer.
    Gilligan MG; Knox PG; Searle PF
    Biotechnol Genet Eng Rev; 2000; 17():497-529. PubMed ID: 11255679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.